Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Tax Provisions (2016 - 2025)

Mimedx's Tax Provisions history spans 13 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 73.31% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $17.7 million, up 15.62%, while the annual FY2025 figure was $17.7 million, 15.61% up from the prior year.
  • Tax Provisions for Q4 2025 was $6.6 million at Mimedx, up from $6.1 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $6.6 million in Q4 2025 and bottomed at -$37.4 million in Q4 2023.
  • The 5-year median for Tax Provisions is $182000.0 (2021), against an average of -$168700.0.
  • The largest annual shift saw Tax Provisions tumbled 133582.14% in 2023 before it surged 7660.81% in 2024.
  • A 5-year view of Tax Provisions shows it stood at -$107000.0 in 2021, then skyrocketed by 126.17% to $28000.0 in 2022, then crashed by 133582.14% to -$37.4 million in 2023, then skyrocketed by 110.2% to $3.8 million in 2024, then soared by 73.31% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Tax Provisions are $6.6 million (Q4 2025), $6.1 million (Q3 2025), and $3.4 million (Q2 2025).